These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2425816)

  • 1. Inhibition of monoamine oxidase by viloxazine in rats.
    Martinez C; Dominiak P; Kees F; Grobecker H
    Arzneimittelforschung; 1986 May; 36(5):800-3. PubMed ID: 2425816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new oxazolidinone derivative AS-8 on serotonin metabolism in the brains of mouse, rat and chick.
    Chilmonczyk Z
    Pol J Pharmacol; 1995; 47(5):445-9. PubMed ID: 8868138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent.
    Yu PH
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):163-71. PubMed ID: 3961266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatographic and tandem mass spectrometric assay for evaluation of in vivo inhibition of rat brain monoamine oxidases (MAO) A and B following a single dose of MAO inhibitors: application of biomarkers in drug discovery.
    Lang W; Masucci JA; Caldwell GW; Hageman W; Hall J; Jones WJ; Rafferty BM
    Anal Biochem; 2004 Oct; 333(1):79-87. PubMed ID: 15351283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lignocaine on monoamine oxidase activity of brain and liver.
    Haque SJ; Poddar MK
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):119-24. PubMed ID: 6748816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats.
    Kitaichi Y; Inoue T; Nakagawa S; Izumi T; Koyama T
    Eur J Pharmacol; 2006 Feb; 532(3):236-45. PubMed ID: 16487506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):207-21. PubMed ID: 7244360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence for the central serotoninergic activity of viloxazine.
    Pawłowski L; Ruczyńska J; Wojtasik E
    Pol J Pharmacol Pharm; 1979; 31(4):261-9. PubMed ID: 523336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of monoamine oxidase A and B in the heart and brain of the rat with amitriptyline, pargyline and pirlindol].
    Schraven E; Reibert R
    Arzneimittelforschung; 1984; 34(10):1258-60. PubMed ID: 6542783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL; Ascher JA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.